                         SEQUENCE LISTING

<110>  Wright State University
 
<120>  PEPTIDE-BASED MOLECULES FOR MODULATING CAR EXPRESSION OR 
       ACCESSIBILITY AND USES THEREOF

<130>  53-25003

<160>  48    

<170>  PatentIn version 3.5

<210>  1
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONA L MEANS

<400>  1

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln 
1               5                   10              


<210>  2
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED BY CONVENTIONAL MEANS

<400>  2

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  3

Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  4

Ala Lys Ala Ala Arg Gln Ala Ala Arg 
1               5                   


<210>  5
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  5

Asp Ala Ala Thr Ala Thr Arg Gly Arg Ser Ala Ala Ser Arg Pro Thr 
1               5                   10                  15      


Glu Arg Pro Arg Ala Pro Ala Arg Ser Ala Ser Arg Pro Arg Arg Val 
            20                  25                  30          


Asp 
    


<210>  6
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  6

Leu Leu Ile Ile Leu Arg Arg Arg Ile Arg Lys Gln Ala His Ala His 
1               5                   10                  15      


Ser Lys 
        


<210>  7
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  7

Arg Val Ile Arg Val Trp Phe Gln Asn Lys Arg Cys Lys Asp Lys Lys 
1               5                   10                  15      


<210>  8
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  8

Leu Gly Thr Tyr Thr Gln Asp Phe Asn Lys Phe His Thr Phe Pro Gln 
1               5                   10                  15      


Thr Ala Ile Gly Val Gly Ala Pro 
            20                  


<210>  9
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  9

Leu Leu Gly Asp Phe Phe Arg Lys Ser Lys Glu Lys Ile Gly Lys Glu 
1               5                   10                  15      


Phe Lys Arg Ile Val Gln Arg Ile Lys Asp Phe Leu Arg Asn Leu Val 
            20                  25                  30          


Pro Arg Thr Glu Ser 
        35          


<210>  10
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  10

Met Ala Asn Leu Gly Tyr Trp Leu Leu Ala Leu Phe Val Thr Met Trp 
1               5                   10                  15      


Thr Asp Val Gly Leu Cys Lys Lys Arg Pro Lys Pro 
            20                  25              


<210>  11
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  11

Gly Trp Thr Leu Asn Ser Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu 
1               5                   10                  15      


Lys Ala Leu Ala Ala Leu Ala Lys Lys Ile Leu 
            20                  25          


<210>  12
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  12

Ala Gly Tyr Leu Leu Gly Lys Ile Asn Leu Lys Ala Leu Ala Ala Leu 
1               5                   10                  15      


Ala Lys Lys Ile Leu 
            20      


<210>  13
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  13

Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10      


<210>  14
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  14

Lys Leu Ala Leu Lys Leu Ala Leu Lys Ala Leu Lys Ala Ala Leu Lys 
1               5                   10                  15      


Leu Ala 
        


<210>  15
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  15

Lys Glu Thr Trp Trp Glu Thr Trp Trp Thr Glu Trp Ser Gln Pro Lys 
1               5                   10                  15      


Lys Lys Arg Lys Val 
            20      


<210>  16
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  16

Lys Glu Thr Trp Phe Glu Thr Trp Phe Thr Glu Trp Ser Gln Pro Lys 
1               5                   10                  15      


Lys Lys Arg Lys Val 
            20      


<210>  17
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  17

Gly Ala Leu Phe Leu Gly Trp Leu Gly Ala Ala Gly Ser Thr Met Gly 
1               5                   10                  15      


Ala Pro Lys Lys Lys Arg Lys Val 
            20                  


<210>  18
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  18

Trp Glu Ala Lys Leu Ala Lys Ala Leu Ala Lys Ala Leu Ala Lys His 
1               5                   10                  15      


Leu Ala Lys Ala Leu Ala Lys Ala Leu Lys Ala Cys Glu Ala 
            20                  25                  30  


<210>  19
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  19

Gly Leu Phe Lys Ala Leu Leu Lys Leu Leu Lys Ser Leu Trp Lys Leu 
1               5                   10                  15      


Leu Leu Lys Ala 
            20  


<210>  20
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  20

Gly Leu Phe Arg Ala Leu Leu Arg Leu Leu Arg Ser Leu Trp Arg Leu 
1               5                   10                  15      


Leu Leu Arg Ala 
            20  


<210>  21
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  21

Ala Gln Ser Gln Ala Gly Ser Leu Val 
1               5                   


<210>  22
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  22

Gln Lys Tyr Val Gln Glu Glu Arg Leu 
1               5                   


<210>  23
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  23

Gln Asn Arg Lys Glu Met Val Tyr Arg 
1               5                   


<210>  24
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  24

Pro Ile Arg Glu Val Glu Asp Glu Cys 
1               5                   


<210>  25
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  25

Ala Gln Ser Lys Asp Gly Ser Ile Val 
1               5                   


<210>  26
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  26

Leu Pro Phe Glu Leu Arg Gly His Leu Val 
1               5                   10  


<210>  27
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  27

Gln Asp Ile Ile Asp Leu Gln Thr Glu Val 
1               5                   10  


<210>  28
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  28

Tyr Lys Thr Asp Gly Ile Thr Val Val 
1               5                   


<210>  29
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  29

Pro Ser Val Lys Ile Ala Thr Leu Val 
1               5                   


<210>  30
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  30

Gly Gly Lys Lys Lys Glu Thr Leu Val 
1               5                   


<210>  31
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  31

Pro Gly Phe Ala Ser Glu Ser Lys Val 
1               5                   


<210>  32
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  32

Ser Arg Thr Arg Arg Glu Thr Gln Leu 
1               5                   


<210>  33
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  33

Asp Glu Asp Glu Gln Val Ser Ala Val 
1               5                   


<210>  34
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  34

Met Ala Arg Thr Ala Arg Ser Lys Val 
1               5                   


<210>  35
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  35

Gln Lys Val Arg Asn Val Thr Leu Val 
1               5                   


<210>  36
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  36

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Ala Gln Ser 
1               5                   10                  15      


Gln Ala Gly Ser Leu Val 
            20          


<210>  37
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  37

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Ala Gln Ser 
1               5                   10                  15      


Lys Asp Gly Ser Ile Val 
            20          


<210>  38
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  38

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Tyr Lys Thr 
1               5                   10                  15      


Asp Gly Ile Thr Val Val 
            20          


<210>  39
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  39

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Gly Gly Lys 
1               5                   10                  15      


Lys Lys Glu Thr Leu Val 
            20          


<210>  40
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  40

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Ser Arg Thr 
1               5                   10                  15      


Arg Arg Glu Thr Gln Leu 
            20          


<210>  41
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  41

Ala Gln Ser Lys Asp Gly Ala Ile Ala 
1               5                   


<210>  42
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  42

Tyr Lys Thr Asp Gly Ile Ala Val Ala 
1               5                   


<210>  43
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  43

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Ala Gln Ser 
1               5                   10                  15      


Lys Asp Gly Ala Ile Ala 
            20          


<210>  44
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  44

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Tyr Lys Thr 
1               5                   10                  15      


Asp Gly Ile Ala Val Ala 
            20          


<210>  45
<211>  68
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  45

Arg Lys Ser Ser Arg Gly Phe Gly Phe Thr Val Val Gly Gly Asp Glu 
1               5                   10                  15      


Pro Asp Glu Phe Leu Gln Ile Lys Ser Leu Val Leu Asp Gly Pro Ala 
            20                  25                  30          


Ala Leu Asp Gly Lys Met Glu Thr Gly Asp Val Ile Val Ser Val Asn 
        35                  40                  45              


Asp Thr Cys Val Leu Gly His Thr His Ala Gln Val Val Lys Ile Phe 
    50                  55                  60                  


Gln Ser Ile Pro 
65              


<210>  46
<211>  76
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  46

Lys Glu Thr Gly Phe Gly Phe Arg Ile Leu Gly Gly Asn Glu Pro Gly 
1               5                   10                  15      


Glu Pro Ile Tyr Ile Gly His Ile Val Pro Leu Gly Ala Ala Asp Thr 
            20                  25                  30          


Asp Gly Arg Leu Arg Ser Gly Asp Glu Leu Ile Cys Val Asp Gly Thr 
        35                  40                  45              


Pro Val Ile Gly Lys Ser His Gln Leu Val Val Gln Leu Met Gln Gln 
    50                  55                  60                  


Ala Ala Lys Gln Gly His Val Asn Leu Thr Val Arg 
65                  70                  75      


<210>  47
<211>  81
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  47

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Arg Lys Ser 
1               5                   10                  15      


Ser Arg Gly Phe Gly Phe Thr Val Val Gly Gly Asp Glu Pro Asp Glu 
            20                  25                  30          


Phe Leu Gln Ile Lys Ser Leu Val Leu Asp Gly Pro Ala Ala Leu Asp 
        35                  40                  45              


Gly Lys Met Glu Thr Gly Asp Val Ile Val Ser Val Asn Asp Thr Cys 
    50                  55                  60                  


Val Leu Gly His Thr His Ala Gln Val Val Lys Ile Phe Gln Ser Ile 
65                  70                  75                  80  


Pro 
    


<210>  48
<211>  89
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PEPTIDE WILL BE CREATED USING CONVENTIONAL MEANS

<400>  48

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln Lys Glu Thr 
1               5                   10                  15      


Gly Phe Gly Phe Arg Ile Leu Gly Gly Asn Glu Pro Gly Glu Pro Ile 
            20                  25                  30          


Tyr Ile Gly His Ile Val Pro Leu Gly Ala Ala Asp Thr Asp Gly Arg 
        35                  40                  45              


Leu Arg Ser Gly Asp Glu Leu Ile Cys Val Asp Gly Thr Pro Val Ile 
    50                  55                  60                  


Gly Lys Ser His Gln Leu Val Val Gln Leu Met Gln Gln Ala Ala Lys 
65                  70                  75                  80  


Gln Gly His Val Asn Leu Thr Val Arg 
                85                  


